Teva Canada Recalls Pregabalin Capsules Over Sertraline Contamination Risk

Teva Canada Ltd. has recalled two lots of Teva-Pregabalin 150 mg capsules after routine testing found potential cross-contamination with sertraline. This poses a serious risk, including potentially fatal allergic reactions like anaphylaxis, for patients with sertraline hypersensitivity. Consumers are advised to consult a healthcare professional before discontinuing use and return affected products.